Similarly, elevated levels of interleukin-22 (IL-22), traditionally associated with the pathogenesis of PSO, have also been observed in AD, where they contribute to epidermal hyperplasia and barrier dysfunction (11, 12). The gene discussed is IL22; the disease is Alzheimer disease.